Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9296224 | Journal of the Chinese Medical Association | 2005 | 8 Pages |
Abstract
Based on the findings of decreased survival and/or growth in OC-117-VGH ovarian adenocarcinoma cells treated with either estrogen or progesterone, we suspect that both hormones act effectively against ER-negative and PR-negative ovarian cancer cells. These findings should lead to a reassessment of hormone therapy for ovarian cancers.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Kung-Chong Chao, Peng-Hui Wang, Ming-Shyen Yen, Chi-Ching Chang, Chin-Wen Chi,